Extracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia
HCC is well known for low glycolysis in the tumors, whereas hypoxia induces glycolytic phenotype and tumor progression. This study was conducted to evaluate the expression of SLCs in human HCCs and investigated whether extracellular nutrient administration related to SLCs in low-glycolytic HCC can p...
Main Authors: | Seon Yoo Kim, Dongwoo Kim, Jisu Kim, Hae Young Ko, Won Jin Kim, Youngjoo Park, Hye Won Lee, Dai Hoon Han, Kyung Sik Kim, Sunghyouk Park, Misu Lee, Mijin Yun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/14/3355 |
Similar Items
-
Growth and Overall Health of Patients with <i>SLC13A5</i> Citrate Transporter Disorder
by: Tanya L. Brown, et al.
Published: (2021-10-01) -
Characterizing a rare neurogenetic disease, SLC13A5 citrate transporter disorder, utilizing clinical data in a cloud-based medical record collection system
by: Emily M. Spelbrink, et al.
Published: (2023-03-01) -
NaCT/SLC13A5 facilitates citrate import and metabolism under nutrient-limited conditions
by: Avi Kumar, et al.
Published: (2021-09-01) -
Targeting Longevity Gene <i>SLC13A5</i>: A Novel Approach to Prevent Age-Related Bone Fragility and Osteoporosis
by: Grit Zahn, et al.
Published: (2023-12-01) -
Mapping the Metabolic Niche of Citrate Metabolism and <i>SLC13A5</i>
by: Fangfang Chen, et al.
Published: (2023-02-01)